Abstract
New Zealand is one of two OECD countries in the world where direct-to-consumer advertising of prescription medicine (DTCA-PM) is permitted. Increase in such activity in recent years has resulted in a disproportionate increase in dispensary volume of heavily advertised medicines. Concern for the potential harm to healthcare consumers and the public healthcare system has prompted the medical profession to call for a ban on DTCA-PM as the best way of protecting the public interest. Such blanket prohibition however also interferes with the public’s right of access to information. This paper will examine if banning DTCA-PM would constitute a justified form of paternalism in the context of today’s New Zealand.
Similar content being viewed by others
Bibliography
GAO. Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. In: Report to Congressional Requestors. United States General Accounting Office; 2002.
PHARMAC Analysis of the increase in dispensing volumes in 2001/2002. In Wellington: PHARMAC; 2002.
Ministry of Health. Direct-to-consumer advertising of prescription medicines in New Zealand. A discussion paper. In. Wellington: Ministry of Health, New Zealand; 2000.
Toop L, Richards D, Dowell T, Tilyard M, Fraser T, Arroll B. Direct to consumer advertising of prescription drugs in New Zealand: For health or for profit? In: New Zealand Departments of General Practice, Christchurch, Dunedin, Wellington and Auckland Schools of Medicine; 2003.
Health Care Program. Direct-to-Consumer Advertising (DTCA) and Marketing of Pharmaceuticals http://www.ncsl.org/programs/health/ rxads.htm). accessed 10 May 2005.
Pratt P. The results of a regulatory compliance survey of direct-to-consumer advertisements for medicines. In. Wellington: Medsafe: 2000.
Dworkin R. Taking Rights Seriously, 7th edn. Cambridge, Massachusetts: Harvard University Press; 1980.
Moonen v Film and Literature Board of Review. In: 2 NZLR. vol. 2: CA; 2000: 16.
Feinberg J. Harm to Others, vol. I. New York: Oxford University Press; 1984.
VanDeVeer D. Paternalistic Intervention — the moral bounds on benevolence. New Jersey: Princeton University Press; 1986.
Feinberg J. Harm to Self, vol. 3. New York: Oxford University Press; 1986.
Hodnett J. Targeting consumers. Medical Marketing & Media 1995; 30(11):91–95.
Calfee J E. Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of public policy and marketing 2002; 21(2):174.
Colmar Brunton. Consumer opinion: Prescription medicines information. Prepared for Department of General Practice Christchurch School of Medicine and Health Sciences. In: Colmar Brunton Social Research Agency; 2003.
Consumers’ Association (UK). DTCA survey results. In. London: Consumers’ Association (UK); 2002.
Massey News. Massey Researchers Question Otago DTCA Survey Conclusions. In: Massey News, Massey University, 2003.
Association of New Zealand Advertisers. Direct to consumer advertising of prescription medicine (DTCA) — part of a well functioning democracy and economy. In: New Zealand Direct Marketing Association Inc., 2004.
Saunders B. DTCA and the cost of asthma inhalers. The New Zealand Medical Journal 2003; 116(1185):672.
Aiken K. J. Direct-to-consumer advertising of prescription drugs: physician survey preliminary results. In: Rockville, Maryland: Division of Drug Marketing, Advertising and Communications, FDA; 2003.
Eagle L, Chamberlain K: DTC Dogma, doubts, diversity and divergence: Perspectives from the medical professions regarding the impact of the promotion of medications direct to consumers-Technical report 03.01. In. Auckland: Massey University; 2003; 1–64.
The Vioxx Recall (http://www.abc.net.au/4corners/content/2005/ s1341036.htm) accessed 10 May 2005
United States Senate Committee on Finance Hearings — ‘FDA, Merck and Vioxx. Putting patient safety first? (http://finance.senate.gov/ sitepages/hearing 111804.htm), accessed 10 May 2005.
Kahn C. How the media influences women’s perceptions of health care. Marketing Health Services 2001 (Spring):13–17.
Allison-Ottey S D, Ruffin K, Allision K B. To do no harm. In: Survey of the physicians of the National Medical Association regarding perceptions on DTC advertisements. Survey of the physicians of the National Medical Association regarding perceptions on DTC advertisements; 2002.
Rights and permissions
About this article
Cite this article
Lau, U. Is banning direct to consumer advertising of prescription medicine justified paternalism?. J. Bioethical Inquiry 2, 69–74 (2005). https://doi.org/10.1007/BF02448845
Issue Date:
DOI: https://doi.org/10.1007/BF02448845